Hepatitis C Stocks

Description:

This portfolio consists of public companies that are researching a cure for Hepatitis C which affects 170 million people worldwide

"The hottest area in drug development right now and for the next couple of years is hepatitis C," said Kris Jenner, whow runs the $1.7 billion T. Rowe Price Health Sciences Fund.

Most Viewed Portfolios

View All

Articles

5 Stocks Poised for Breakouts

05.24.13 | 01:52 PM

 MADISON, Wis. (Stockpickr) -- Trading stocks that trigger major breakouts can lead to massive profits. Once a stock trends to a new high or t...

5 Dividend Stocks Getting Ready to Hike Payouts

05.24.13 | 12:24 PM

BALTIMORE (Stockpickr) -- If you don't own dividend stocks right now, you're doing something wrong. Even though most investors have been watching...

More Articles
blog comments powered by Disqus
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter